Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Jan 24;10(425):eaao1613.
doi: 10.1126/scitranslmed.aao1613.

Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition

Mohammed Selman  1   2 , Paula Ou  1   3 , Christopher Rousso  1   3 , Anabel Bergeron  1   3 , Ramya Krishnan  1   2 , Larissa Pikor  1 , Andrew Chen  1 , Brian A Keller  1   2 , Carolina Ilkow  1   2 , John C Bell  1   2 , Jean-Simon Diallo  4   2
Affiliations

Dimethyl fumarate potentiates oncolytic virotherapy through NF-κB inhibition

Mohammed Selman et al. Sci Transl Med. .

Abstract

Resistance to oncolytic virotherapy is frequently associated with failure of tumor cells to get infected by the virus. Dimethyl fumarate (DMF), a common treatment for psoriasis and multiple sclerosis, also has anticancer properties. We show that DMF and various fumaric and maleic acid esters (FMAEs) enhance viral infection of cancer cell lines as well as human tumor biopsies with several oncolytic viruses (OVs), improving therapeutic outcomes in resistant syngeneic and xenograft tumor models. This results in durable responses, even in models otherwise refractory to OV and drug monotherapies. The ability of DMF to enhance viral spread results from its ability to inhibit type I interferon (IFN) production and response, which is associated with its blockade of nuclear translocation of the transcription factor nuclear factor κB (NF-κB). This study demonstrates that unconventional application of U.S. Food and Drug Administration-approved drugs and biological agents can result in improved anticancer therapeutic outcomes.

PubMed Disclaimer

Similar articles

See all similar articles

Cited by

See all "Cited by" articles

Publication types

Grants and funding

LinkOut - more resources